Insulin human

The University of Nebraska Medical Center, a state agency within the University of Nebraska system, awarded a purchase order to Fisher Scientific Co LLC, a medical supply vendor based in Chicago, Illinois, on February 11, 2026. The contract, identified as 4800178574, is valued at $282.74 and covers the procurement of one unit of Insulin Human (material number NC1674236) at a unit price of $282.74. The purchase order is classified as a standard PO (Purchase Order) under the Standard Terms of Purchase established by the University of Nebraska Board of Regents and carries tax-exempt status number 05-8905401.

Delivery of the insulin is scheduled for February 16, 2026, on a free on board (FOB) destination basis with freight prepaid to the University of Nebraska Medical Center Shipping and Receiving facility located at 601 South Saddle Creek Road, Omaha, Nebraska 68106. Payment terms are Net 30 with an early payment discount option available. The vendor is required to acknowledge acceptance of the purchase order within ten days of the order date and ensure the purchase order number appears on all packages, invoices, and related documentation. Invoicing is directed to the University of Nebraska Medical Center Accounts Payable office.